These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 26370061

  • 1. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
    Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S.
    Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
    [Abstract] [Full Text] [Related]

  • 2. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M, Hamza M.
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [Abstract] [Full Text] [Related]

  • 3. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282
    [Abstract] [Full Text] [Related]

  • 4. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T, Nishigaki K, Kinomura Y, Tanaka T, Yamada Y, Kawasaki M, Minatoguchi S.
    Int J Cardiol; 2015 Sep 15; 195():228-34. PubMed ID: 26048382
    [Abstract] [Full Text] [Related]

  • 5. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May 15; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
    Jaffery Z, Verma A, White CJ, Grant AG, Collins TJ, Grise MA, Jenkins JS, McMullan PW, Patel RA, Reilly JP, Thornton SN, Ramee SR.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):921-6. PubMed ID: 21542122
    [Abstract] [Full Text] [Related]

  • 7. A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.
    Panagiotou A, Trendelenburg M, Heijnen IAFM, Moser S, Bonati LH, Breidthardt T, Fahrni G, Kaiser C, Jeger R, Osthoff M.
    JACC Cardiovasc Interv; 2020 Apr 13; 13(7):833-842. PubMed ID: 32171721
    [Abstract] [Full Text] [Related]

  • 8. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
    Vasheghani-Farahani A, Sadigh G, Kassaian SE, Khatami SM, Fotouhi A, Razavi SA, Mansournia MA, Yamini-Sharif A, Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Borumand MA, Esfehani FA, Darabian S.
    Am J Kidney Dis; 2009 Oct 13; 54(4):610-8. PubMed ID: 19619921
    [Abstract] [Full Text] [Related]

  • 9. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.
    J Cardiovasc Med (Hagerstown); 2010 Mar 13; 11(3):199-206. PubMed ID: 19829124
    [Abstract] [Full Text] [Related]

  • 10. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y, Wei Q, Cai J, Shi Y, Zhang Y, Yao L, Wang X, Lin S, Li Y, Lv J, Zhou B, Du R.
    Heart Vessels; 2016 Nov 13; 31(11):1776-1782. PubMed ID: 26874946
    [Abstract] [Full Text] [Related]

  • 11. Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
    Quintavalle C, Anselmi CV, De Micco F, Roscigno G, Visconti G, Golia B, Focaccio A, Ricciardelli B, Perna E, Papa L, Donnarumma E, Condorelli G, Briguori C.
    Circ Cardiovasc Interv; 2015 Sep 13; 8(9):e002673. PubMed ID: 26333343
    [Abstract] [Full Text] [Related]

  • 12. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.
    Eur Rev Med Pharmacol Sci; 2013 Feb 13; 17 Suppl 1():13-21. PubMed ID: 23436661
    [Abstract] [Full Text] [Related]

  • 13. The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration.
    Choi MJ, Yoon JW, Han SJ, Choi HH, Song YR, Kim SG, Oh JE, Lee YK, Seo JW, Kim HJ, Noh JW, Koo JR.
    Int J Cardiol; 2014 Oct 20; 176(3):941-5. PubMed ID: 25200848
    [Abstract] [Full Text] [Related]

  • 14. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.
    Catheter Cardiovasc Interv; 2011 Aug 01; 78(2):198-201. PubMed ID: 20949583
    [Abstract] [Full Text] [Related]

  • 15. Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial.
    Liu J, Xie Y, He F, Gao Z, Hao Y, Zu X, Chang L, Li Y.
    Biomed Res Int; 2016 Aug 01; 2016():5985327. PubMed ID: 26949703
    [Abstract] [Full Text] [Related]

  • 16. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
    Rezaei Y, Khademvatani K, Rahimi B, Khoshfetrat M, Arjmand N, Seyyed-Mohammadzad MH.
    J Am Heart Assoc; 2016 Mar 15; 5(3):e002919. PubMed ID: 27068631
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome.
    Reyes LF, Severiche-Bueno DF, Bustamante CA, Murillo S, Soni NJ, Poveda M, Gomez E, Buitrago R, Rodriguez A.
    BMC Nephrol; 2020 Apr 22; 21(1):143. PubMed ID: 32321453
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A, Möllmann H, Hamm C, Nef H.
    Scand J Clin Lab Invest; 2014 Mar 22; 74(2):81-8. PubMed ID: 24304491
    [Abstract] [Full Text] [Related]

  • 19. The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients.
    Hami M, Bigdeli A, Khameneh Bagheri R, Rajabi O, Salehi M, Zahedi Avval F.
    Iran J Kidney Dis; 2019 Sep 22; 13(5):304-309. PubMed ID: 31705746
    [Abstract] [Full Text] [Related]

  • 20. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.
    Int J Cardiol; 2010 Feb 04; 138(3):239-45. PubMed ID: 18793808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.